Screener
Sabra Healthcare SBRA Accounts Receivable, Credit Loss Expense (Reversal)
Accounts Receivable, Credit Loss Expense (Reversal) at other companies
Other financials
Where this comes from
Reported directly by Sabra Healthcare in its filing.
Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.
The source filing: Sabra Healthcare’s 10-Q, filed April 29, 2026.
- Filed
- Apr 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001492298-26-000012
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Triple-net portfolio operating expenses | 3,773 | 3,479 |
| Senior housing - managed portfolio operating expenses | 81,869 | 56,454 |
| General and administrative | 14,862 | 12,728 |
| Recovery of loan losses | (213) | (173) |
| Impairment of real estate | 440 | — |
| Total expenses | 182,271 | 143,082 |
| Other (expense) income | (55) | 38 |
| Income before income from unconsolidated joint ventures and income tax expense | 39,427 | 40,499 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Sabra Healthcare's accounts receivable, credit loss expense (reversal)?
- Sabra Healthcare (SBRA) reported accounts receivable, credit loss expense (reversal) of -$213K in Q1 2026.
- How has Sabra Healthcare's accounts receivable, credit loss expense (reversal) changed year-over-year?
- Sabra Healthcare's accounts receivable, credit loss expense (reversal) decreased by 23.1% year-over-year, from -$173K to -$213K.
- What is the long-term trend for Sabra Healthcare's accounts receivable, credit loss expense (reversal)?
- Over 3 years (2021 to 2025), Sabra Healthcare's accounts receivable, credit loss expense (reversal) has grown at a -35.7% compound annual growth rate (CAGR), from $3.94M to -$1.05M.
Ask your AI about Sabra Healthcare's accounts receivable, credit loss expense (reversal).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude